ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,300.33
-0.14%
Dow Jones
43,828.06
-0.20%
Gold vs US Dollar
2,648.955
0.00%
Brent Oil
74.135
0.00%
Bitcoin
102,205.42
0.74%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Neurocrine Biosciences Inc (NBIX) Share Price

NBIX Neurocrine Biosciences Inc

128.47
1.68 (1.33%)
14 Dec 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Neurocrine Biosciences Inc NASDAQ:NBIX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   1.68 1.33 128.47 126.83 128.00 127.05 125.61 126.7 781,662 00:59:03   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics 1.89B 249.7M 2.4662 51.42 12.84B
 Type  Size  Price  Time  Units 
 9 3 128.50 00:49:24 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore NBIX News
13/12/202423:55PRNUSNeurocrine Biosciences Announces FDA Approval of CRENESSITY™ (crinecerfont), a First-in-Class Treatment for Children and Adults With Classic Congenital Adrenal Hyperplasia
03/12/202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
29/11/202418:41EDGAR2Form 144 - Report of proposed sale of securities
26/11/202421:01PRNUSNeurocrine Biosciences to Participate at Investor Conferences in December
12/11/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
08/11/202400:42EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
07/11/202413:30PRNUSNeurocrine Biosciences Presents New KINECT®-HD Data Showing Consistent Efficacy Across 19 Subgroups and Improvements in Aspects of Emotional Health With INGREZZA® (valbenazine) Capsules
Period
Draw mode
Data Downloads for NBIX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Neurocrine Biosciences Inc Articles